Tamtam Try Tamtam free
ATS Corporation logo

ATS Corporation account plan

Global manufacturing automation solutions

At a glance

ATS Corporation is a Canadian builder of automated manufacturing and assembly systems, with $2,972.9M of fiscal 2026 revenues and over 7,000 people.

ATS Corporation, founded in 1978 and listed on the TSX and NYSE, plans, designs, builds, commissions and services automated manufacturing and assembly systems, automation products and test solutions, favouring regulated industries such as life sciences and nuclear. It employs over 7,000 people at more than 65 manufacturing facilities and over 85 offices in North America, Europe, Asia and Oceania. In fiscal 2026 (year ended March 31, 2026) revenues were $2,972.9M (+17.4%), adjusted EBITDA $413.0M and net income $71.7M. Order Bookings were $2,952M and backlog $1,958M at year-end.

Business units

Strategic priorities

15% margin target
ATS aims to expand its adjusted earnings from operations margin to 15% over time from about 10%, and CEO Doug Wright believes it can operate above that target.
Fixed Cost Transformation Program
A multi-phase program designed to deliver $65M-$75M of annualised savings, about 250 basis points of margin, cutting about 10% of square footage and 300 to 400 workers including subcontractors.
Radiopharma and nuclear growth
ATS is adding capacity in radiopharma, including the Bologna facility expansion and service centers in the central United States and Melbourne, and expects to expand U.S. facilities for nuclear.
Reoccurring revenue and aftermarket
Reoccurring revenues are expected at 25%-35% of revenues, with services embedded into operating units and digital and data-driven services developed.
Disciplined acquisitions
Growth through acquisition remains part of the Build, Grow and Expand strategy, under a cash return on investment framework that sets return thresholds.

Latest results

In Q2 fiscal 2027 (quarter ended September 27, 2026) revenues fell 8.6% to $665.8M from $728.5M, mainly on normalised GLP-1-related activity, and adjusted earnings from operations fell to $57.4M (8.6% margin) from $79.1M (10.9%). ATS posted a net loss of $5.0M. Order Bookings rose 12.7% to $827M, led by Life Sciences, and backlog stood at $2,009M. Because packaging orders were delayed by U.S. Section 338 tariffs, management no longer expects modest revenue growth and margin expansion in fiscal 2027; Q3 revenue is guided at $640M-$680M.

Investments and deals

Acquisitions
Heidolph and Paxiom contributed $43.2M of revenue in fiscal 2026; the acquisition pipeline is described as healthy across several end markets.
Capital expenditure
Fiscal 2027 capex is now expected at $60M-$80M.
Facility sales
After Q2 fiscal 2027, two U.S. facilities were sold for $71.2M, one leased back to support the U.S. nuclear business, helping fund restructuring.
Share buybacks
2,244,461 shares were repurchased under the NCIB for $61.3M in fiscal 2027 to date.

Challenges and risks

U.S. tariffs
Section 338 tariffs hit packaging equipment made in Canada and sold into the U.S.; sales from Canadian and European operations into the U.S. are just over 20% of adjusted revenues.
GLP-1 normalisation
Lower GLP-1-related activity drove a $66.1M organic revenue decline in Q2 fiscal 2027.
Leverage
Net debt to pro forma adjusted EBITDA was 3.1 times, expected to remain moderately above the 2.0-3.0 times range for the rest of fiscal 2027.
Internal controls
Disclosure controls are not effective because of a material weakness in one international division linked to ERP transition delays.
Underused capacity
The CEO's review found portions of the business with excess capacity and infrastructure not generating required returns, notably in Europe.

What leadership says

“Growth through acquisition will remain a key component of our strategy”

Doug Wright, CEO · Shareholder letter, ATS 2026 Annual Report

“I have even more conviction today than I did in coming to ATS”

Doug Wright, CEO · Q1 fiscal 2027 earnings call, August 6, 2026

“These are whole factories that are being implemented by these customers in radiopharma and med device”

Doug Wright, CEO · Q2 fiscal 2027 earnings call, November 4, 2026

“we do not expect to achieve our previous goals for modest revenue growth and for margin expansion in the year”

Anne Cybulski, Interim CFO · Q2 fiscal 2027 earnings call, November 4, 2026

Where a supplier can help

Footprint consolidation services
Tied to the Fixed Cost Transformation Program: facility closures, equipment relocation and real estate advisory as square footage falls by about 10%.
Components for radiopharma and nuclear builds
Tied to the radiopharma and nuclear growth priority: containment, shielding, precision components and U.S. manufacturing capacity for whole-factory projects.
ERP and controls remediation
Tied to the internal controls challenge: ERP implementation and audit partners for the international division's transition.
Aftermarket and digital service tools
Tied to the reoccurring revenue priority: field service software, connected-equipment analytics and spare parts logistics.
Trade and supply chain advisory
Tied to the U.S. tariffs challenge: customs, sourcing and production-shifting support for Canadian-made equipment sold into the U.S.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like ATS Corporation?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about ATS Corporation

What does ATS Corporation do?

ATS plans, designs, builds, commissions and services automated manufacturing and assembly systems, automation products and test solutions for life sciences, food and beverage, consumer, industrial and energy customers.

What was ATS's revenue in fiscal 2026?

Revenues were $2,972.9M in the year ended March 31, 2026, up 17.4%, with net income of $71.7M.

How many employees does ATS have?

Over 7,000 people, including approximately 2,200 engineers, at more than 65 manufacturing facilities and over 85 offices.

Who leads ATS Corporation?

Doug Wright is Chief Executive Officer, Anne Cybulski is Interim Chief Financial Officer and Michael Martino was selected as Chair of the Board.

What is ATS's strategy?

ATS follows a Build, Grow and Expand strategy, targets a 15% adjusted operating margin through fixed cost cuts and aftermarket growth, and invests in radiopharma and nuclear.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)